The scientist’s investigation covers issues in Hepatocellular carcinoma, Surgery, Internal medicine, Cancer research and Pathology. Pierce K. H. Chow interconnects Hepatitis B, Survival rate, Randomized controlled trial, Carcinoma and Radiology in the investigation of issues within Hepatocellular carcinoma. His studies examine the connections between Surgery and genetics, as well as such issues in Liver function, with regards to Therapeutic approach, Guideline and Performance status.
Pierce K. H. Chow combines subjects such as Gastroenterology and Oncology with his study of Internal medicine. His Cancer research study integrates concerns from other disciplines, such as HDAC3, Acetylation, Growth inhibition and MAPK/ERK pathway. His Pathology research focuses on Intraductal papillary mucinous neoplasm and how it connects with Pancreatic duct, Univariate analysis, Cystadenocarcinoma and Cystic Neoplasm.
Hepatocellular carcinoma, Internal medicine, Surgery, Cancer research and Gastroenterology are his primary areas of study. His study explores the link between Hepatocellular carcinoma and topics such as Radiology that cross with problems in Nuclear medicine. His research integrates issues of Hepatectomy, Oncology and Endocrinology in his study of Internal medicine.
His research in Cancer research intersects with topics in Gene, Immune system and Growth inhibition, Cell growth. His study in Gastroenterology is interdisciplinary in nature, drawing from both Pancreas, Lymphocyte and Univariate analysis. His studies in Retrospective cohort study integrate themes in fields like Pancreatectomy and Laparoscopy.
His primary areas of study are Hepatocellular carcinoma, Internal medicine, Cancer research, Surgery and Abdominal surgery. His Hepatocellular carcinoma research integrates issues from Tumor microenvironment, Radiology and Single institution. He has researched Internal medicine in several fields, including Gastroenterology, Resection and Oncology.
His Gastroenterology study also includes fields such as
Pierce K. H. Chow mostly deals with Hepatocellular carcinoma, Cancer research, Internal medicine, Surgery and Tumor microenvironment. His Hepatocellular carcinoma research focuses on HCCS in particular. His biological study spans a wide range of topics, including Cancer, Cell growth, CD8, Immune system and Gene.
His study in the field of Cohort is also linked to topics like APOA4. In Surgery, he works on issues like Cirrhosis, which are connected to microRNA. His Tumor microenvironment study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen.
Hepatology International (2010)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Donald Poon;Benjamin O Anderson;Li-Tzong Chen;Koichi Tanaka.
Lancet Oncology (2009)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles;Anne-Laure Puaux;Xiaojie Wang;Benjamin Toh.
Journal of Clinical Investigation (2010)
Perforation of the Gastrointestinal Tract Secondary to Ingestion of Foreign Bodies
Brian K.P. Goh;Pierce K.H. Chow;Hak-Mien Quah;Hock-Soo Ong.
World Journal of Surgery (2006)
Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
Waraporn Chan-on;Waraporn Chan-on;Maarja-Liisa Nairismägi;Choon Kiat Ong;Weng Khong Lim.
Nature Genetics (2013)
Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Brian K. P. Goh;Yu-Meng Tan;Yaw-Fui Alexander Chung;Peng-Chung Cheow.
Archives of Surgery (2008)
Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Yanna Cui;Qingxing Xu;Pierce Kah-Hoe Chow;Pierce Kah-Hoe Chow;Deping Wang.
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul;Apinya Jusakul;Ioana Cutcutache;Chern Han Yong;Jing Quan Lim.
Cancer Discovery (2017)
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Hung Huynh;Van Chanh Ngo;Joseph Fargnoli;Mark Ayers.
Clinical Cancer Research (2008)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K.H. Chow;Mihir Gandhi;Say Beng Tan;Maung Win Khin.
Journal of Clinical Oncology (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: